PubMed=2778352; DOI=10.1111/1523-1747.ep12284060
Nishigori C., Miyachi Y., Imamura S., Takebe H.
Reduced superoxide dismutase activity in xeroderma pigmentosum fibroblasts.
J. Invest. Dermatol. 93:506-510(1989)

PubMed=1814424
Nishigori C., Fujisawa H., Uyeno K., Kawaguchi T., Takebe H.
Xeroderma pigmentosum patients belonging to complementation group F and efficient liquid-holding recovery of ultraviolet damage.
Photodermatol. Photoimmunol. Photomed. 8:146-150(1991)

PubMed=7905727; DOI=10.1001/archderm.1994.01690020057009
Nishigori C., Moriwaki S., Takebe H., Tanaka T., Imamura S.
Gene alterations and clinical characteristics of xeroderma pigmentosum group A patients in Japan.
Arch. Dermatol. 130:191-197(1994)

PubMed=8596539; DOI=10.1016/0921-8777(95)00052-6
Sato M., Nishigori C., Yagi T., Takebe H.
Aberrant splicing and truncated-protein expression due to a newly identified XPA gene mutation.
Mutat. Res. 362:199-208(1996)

PubMed=9580660; DOI=10.1093/hmg/7.6.969
Matsumura Y., Nishigori C., Yagi T., Imamura S., Takebe H.
Characterization of molecular defects in xeroderma pigmentosum group F in relation to its clinically mild symptoms.
Hum. Mol. Genet. 7:969-974(1998)